Purpose

The purpose of this study is to research the effects of partial sleep deprivation (sleep restriction) in a group of individuals whose parents have high blood pressure compared to a group of individuals whose parents have normal blood pressure.

Condition

Eligibility

Eligible Ages
Between 18 Years and 35 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy adults aged 18-35 years - Absence of any significant medical or psychiatric disease (as per the investigators' judgment) - Nonsmoker - Nonpregnant - History of normal sleep duration (reported average sleep duration between 7-9 hours/night and no habitual napping) - Hypertension status information available for both biological parents - Ability to understand study procedures and to comply with them for the entire length of the study - Ability to understand English and provide informed consent

Exclusion Criteria

  • Age <18 or >35 years - Body mass index <18.5 or ≥30 kg/m2 - Pregnant or lactating - Unable to determine history of HTN in participant's biological parents or subject being adopted - Use of tobacco, vaping, marijuana products or other drugs - Excessive caffeine consumption (>400 mg/day) - Excessive alcohol consumption (>7 drinks/week for women, >14 drinks/week for men) - Office SBP/DBP ≥130/80 mmHg - Daytime ambulatory SBP/DBP ≥130/80 mmHg - Fasting glucose ≥126 mg/dl - Glomerular filtration rate <60 mL/min/BSA - History of significant medical or psychiatric disorders (as per the investigators' judgment) - Regular use of prescription medications other than contraceptives - Use of melatonin supplements or any other over-the-counter sleep aid - Moderate-to-severe sleep disordered breathing (apnea/hypopnea index, AHI ≥15) or mild sleep disordered breathing (AHI 5-15) with daytime sleepiness (Epworth Sleepiness Scale >10) - Moderate-to-severe insomnia (Insomnia Severity Index >14) - Restless leg syndrome (as per the Cambridge-Hopkins questionnaire) - Excessive daytime sleepiness (Epworth Sleepiness Scale >15) - Extreme chronotype (Morningness-Eveningness Questionnaire >69 or <31) - Night shift work - Ongoing participation in other research studies (as per the investigators' judgment) - Any other medical, geographic, or social factor making study participation impractical - Not English-speaking and/or inability to provide informed consent - Exclusionary for blood draws: hemoglobin <11.6 g/dL in women / <13.2 g/dL in men; participants with measured hemoglobin levels below these thresholds will be allowed to continue participate in study tests and procedures not involving blood draws.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Primary Purpose
Other
Masking
Double (Investigator, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Study Sequence AB
Sleep restriction condition in the first period and normal sleep condition in the second period. Each period will consist of a 10-day inpatient visit comprising a 3-day/2-night baseline, followed by a 5-day/5-night experimental phase, and a 2-day/2-night recovery phase.
  • Behavioral: Partial sleep deprivation (sleep restriction)
    During the experimental segment the sleep opportunity will be restricted to 5 hours/night. During the acclimation and recovery phases a 9-hour/night sleep opportunity will be provided.
  • Behavioral: Normal sleep
    During the normal sleep condition a 9-hour/night sleep opportunity will be provided throughout the 10-day inpatient visit.
Experimental
Study Sequence BA
Normal sleep condition in the first period and sleep restriction condition in the second period. Each period will consist of a 10-day inpatient visit comprising a 3-day/2-night baseline, followed by a 5-day/5-night experimental phase, and a 2-day/2-night recovery phase.
  • Behavioral: Partial sleep deprivation (sleep restriction)
    During the experimental segment the sleep opportunity will be restricted to 5 hours/night. During the acclimation and recovery phases a 9-hour/night sleep opportunity will be provided.
  • Behavioral: Normal sleep
    During the normal sleep condition a 9-hour/night sleep opportunity will be provided throughout the 10-day inpatient visit.

Recruiting Locations

Mayo Clinic in Rochester
Rochester 5043473, Minnesota 5037779 55905

More Details

Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Sabah Munir
(507)255-0151
Munir.Sabah@mayo.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.